If you are not happy with the results below please do another search
“We want to introduce Precision AQ as a team of advisors, experts, and creators to sit in the room with our clients to partner, looking at access as a continuum,” President Doug Fulling told Med Ad News. “This has been 10 years in the making. We started the rebrand process six months ago, but the reason that we’re doing this now is we want to simplify our North Star and where we’re going in the marketplace.”
In recognition of Clinical Trials Day, The Trial for #ClinicalEquality –a longstanding and widely celebrated initiative from FCB Health New York, an IPG Health company – continues the fight to increase equity in clinical trials with the next phase of its campaign entitled, “Worth Less.”
Earlier this month, Neuralink said tiny wires implanted in the brain of its first patient had pulled out of position. Reuters reported last week, citing sources, the company knew from animal testing that the wires might retract.
H4B Chelsea President Violet Aldaia was recently elected the new board chair of the Coalition for Healthcare Communication (CHC). Med Ad News spoke with Aldaia to get a quick take on the issues she feels are most important for CHC to address this year.
Pfizer’s Wyeth unit notched a legal victory over AstraZeneca on Friday as a federal jury found the British-Swedish company violated two key patents in developing and marketing its lung cancer drug Tagrisso.
In an oral decision, the European patent authority maintained the validity of Moderna’s patent ‘949 which describes and protects specific alterations to mRNA molecules designed to lower its immunogenicity, bypass the immune system and boost its translation in the body—as well as the potential uses of the modified mRNA.
According to key opinion leaders (KOLs) interviewed by GlobalData, the prevalence of HIV will reduce in the future, partly due to better treatment options, the availability of PrEP, and the development of prophylactic vaccines.
The facility, which will be the drugmaker’s first end-to-end antibody-drug conjugate production site, will be supported by the Singapore Economic Development Board.
Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk’s weight-loss drug Wegovy, researchers reported today.
Peregrine Market Access, a full-service consulting, communications, and commercialization partner for the life sciences industry, has promoted Alyson Popa to account director, Jennifer Sparano to senior vice president, director of corporate communications, and Stacey Thomas to vice president, director of project management.